OPEN ENROLLMENT
Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures
Study EP0162 is a double-blind, randomized, placebo-controlled, multi-center, parallel-group, Phase 3 study to investigate the efficacy and safety of Staccato alprazolam in an outpatient setting in…
- Investigator
- Ramon Bautista, Suparna Krishnaiengar, Katherine Zarroli
- IRB Number
- WIRB20216831
- Ages
- 12 Years
- Sexes
- All
- Location
- Jacksonville
An Outpatient Physical Therapy and Golf Program Designed for Individuals with Movement Disorders
The importance of physical activity for individuals with movement disorders, including Parkinson disease and Essential tremor, has been established. Barriers including patient engagement continue to…
- Investigator
- Michael Pulley
- IRB Number
- IRB202202232
- Location
- Jacksonville
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of staccato alprazolam in study participants 12 years of age and older with stereotypical prolonged seizures (20216843)
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of staccato alprazolam in study participants 12 years of age and older with stereotypical prolonged…
- Investigator
- Suparna Krishnaiengar
- IRB Number
- 1324368
- Location
- Jacksonville
OPEN ENROLLMENT
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke
This Study is testing the study drug to see if it can be used safely and effectively in people who have experienced an ischemic stroke in the past 24 hours and cannot take other approved…
- Investigator
- Benjamin Alwood, Scott Silliman
- IRB Number
- 20250035
- Ages
- 18 Years – 90 Years
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke
This Study is testing the study drug to see if it can be used safely and effectively in people who have experienced an ischemic stroke in the past 24 hours and cannot take other approved…
- Investigator
- Benjamin Alwood, Scott Silliman
- IRB Number
- 20250035
- Ages
- 18 Years – 90 Years
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
BHV7000-304: A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000
This is a research study to test a new investigational drug. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA). The main purpose of this…
- Investigator
- Ramon Bautista, Suparna Krishnaiengar, Katherine Zarroli
- IRB Number
- 20242840
- Ages
- 18 Years – 75 Years
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
Sleep SMART: Sleep for Stroke Management And Recovery Trial
Investigator-initiated, phase 3 multicenter, prospective randomized open-, blinded-endpoint (PROBE) controlled trial to test whether treatment of obstructive sleep apnea (OSA) with continuous…
- Investigator
- Benjamin Alwood, Scott Silliman
- IRB Number
- CED000000869
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
ASPIRE: Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery
The ASPIRE study is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of apixaban, compared with aspirin, in patients with a recent ICH and non-valvular…
- Investigator
- Benjamin Alwood, Kimberly McPhearson
- IRB Number
- CED000000883
- Ages
- 18 Years – NA
- Sexes
- All
- Location
- Jacksonville